Douglas Brand - Concepedia

Author

Douglas Brand

Institute of Cancer Research ORCID

Also Known As

Brand, Douglas, Chris Parker, D Brand, D. Brand, D.H. Brand, Douglas Brand, Douglas H Brand, Douglas H. Brand

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Royal Marsden Hospital Clatterbridge Cancer Centre NHS Foundation Trust University College London Royal Marsden NHS Foundation Trust

About

Douglas Brand is an author at Institute of Cancer Research specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	66
2	Health Sciences	2	2	45
3	Radiation Medicine	2	2	50
4	Brachytherapy	2	2	50
5	Cancer Therapeutics	1	1	16

Douglas Brand

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial Douglas Brand, Alison Tree, Peter Ostler, The Lancet Oncology	2019	519
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial Alison Tree, Peter Ostler, H. van der Voet, The Lancet Oncology	2022	280
Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy Angela Pathmanathan, H. McNair, Maria A. Schmidt, British Journal of Radiology	2019	69
Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy Fractionation Anna Wilkins, Olivia Naismith, Douglas Brand, International Journal of Radiation OncologyBiologyPhysics	2020	50
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial Douglas Brand, Sarah C. Brüningk, Anna Wilkins, International Journal of Radiation OncologyBiologyPhysics	2021	48
Improving fiducial and prostate capsule visualization for radiotherapy planning using<scp>MRI</scp> Angela Pathmanathan, Maria A. Schmidt, Douglas Brand, Journal of Applied Clinical Medical Physics	2019	34
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP Trial Douglas Brand, Sarah C. Brüningk, Anna Wilkins, International Journal of Radiation OncologyBiologyPhysics	2022	30
PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa). Nicholas John Van As, Douglas Brand, Alison Tree, Journal of Clinical Oncology Acute Toxicity SeverityRadiation MedicineRadiation TherapyMedicineBrachytherapy	2019	29
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study Ragu Ratnakumaran, Victoria Hinder, Douglas Brand, Cancers	2023	23
Patterns of recurrence after prostate bed radiotherapy Douglas Brand, Joanna I. Parker, David P. Dearnaley, Radiotherapy and Oncology UrologyRadiation MedicineMedicineCancer RecurrenceBrachytherapy	2019	21

Page 1